Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning-Reference-Cited by-同舟云学术

Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning

Published:2013-01 Issue:1 Volume:19 Page:117-122
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Raiola Anna Maria,Dominietto Alida,Ghiso Anna,Di Grazia Carmen,Lamparelli Teresa,Gualandi Francesca,Bregante Stefania,Van Lint Maria Teresa,Geroldi Simona,Luchetti Silvia,Ballerini Filippo,Miglino Maurizio,Varaldo Riccardo,Bacigalupo Andrea

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference21 articles.

1. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype;Aversa;N Engl J Med,1998

2. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse;Aversa;J Clin Oncol,2005

3. The history and future prospective of haplo-identical stem cell transplantation;Handgretinger;Cytotherapy,2008

4. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation;Lu;Blood,2006

5. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide;Luznik;Biol Blood Marrow Transplant,2008

Cited by 314 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved Outcome of Allogeneic Transplantation in Older Patients Treated for Myeloid Malignancies Using Post-Transplantation Cyclophosphamide and Reduced Duration of Immune Suppression;Transplantation and Cellular Therapy;2024-08

2. Comparison of Three Graft-versus-Host Disease Prophylaxis Strategies after T Cell-Replete Haploidentical Hematopoietic Transplantation: Tacrolimus versus Calcineurin Inhibitors + Mycophenolate Mofetil versus Sirolimus + Mycophenolate Mofetil;Transplantation and Cellular Therapy;2024-08

3. Longitudinal outcome over four decades of allogeneic stem cell transplantation: a single center experience;Bone Marrow Transplantation;2024-06-25

4. The use of haploidentical stem cell transplant as an alternative donor source in patients with decreased access to matched unrelated donors;Hematology;2024-05-16

5. Clinical effects of tacrolimus blood concentrations early after allogeneic hematopoietic stem cell transplantation;Cytotherapy;2024-05